TrivarX Limited (ASX:TRI)
0.0230
+0.0010 (4.55%)
Jun 16, 2026, 1:58 PM AEST
TrivarX Company Description
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.
The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market.
The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023.
TrivarX Limited was incorporated in 1987 and is based in Hawthorn East, Australia.
TrivarX Limited

| Country | Australia |
| Founded | 1987 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 6 |
Contact Details
Address: Suite 1.01 Hawthorn East, VIC 3123 Australia | |
| Phone | 61 8 6189 1155 |
| Website | trivarx.com |
Stock Details
| Ticker Symbol | TRI |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000MEB8 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Kai Sun | Chief Operating Officer |
| Dr. Anthony James Keating | Executive Director |
| Josh Purdy | Public Relations Director |
| Massimiliano Grassi | Head of Artificial Intelligence |
| Cameron Peter Jones C.A. | Joint Company Secretary |
| Nova Anne Taylor | Joint Company Secretary |